Request Services Now

CTSA Ansible - May 2021

CTSA Ansible LogoThe Spotlight
CTSA Program Hubs Will Help Implement the ACTIV-6 Clinical Trial
The National Institutes of Health will fund a large, randomized, placebo controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. The trial is part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership and overseen by NCATS.

What's New: Upcoming Events
Un-Meeting: Exploring the Inclusion of Community Hospitals in Clinical Research
The Center for Leading Innovation and Collaboration (CLIC) will host a virtual Un-Meeting on Thursday, May 27 titled “Exploring the Inclusion of Community Hospitals in Clinical Research.” Participants will discuss how to work with community hospitals when preparing for a future public health emergency, when recruiting for academic clinical trials and when working to increase participant diversity in clinical trials.

Updates and Reminders from NIH